학술논문

Updated results of a randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 20 2007, 25 18, 2p. Supplement: S
Subject
Language
English
ISSN
15277755